Christopher & Banks (CBK) Reports Q4 Loss of $0.23/Share
Tweet
Share
E-mailGet Alerts CBK Hot Sheet
Price: $0.35 --0%
Financial Fact:
Operating income (loss): 3.62M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Operating income (loss): 3.62M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Christopher & Banks (NYSE: CBK) reported Q4 EPS of ($0.23), versus ($0.46) reported last year. Revenue for the quarter came in at $92.3 million, versus $85 million reported last year.
For earnings history and earnings-related data on Christopher & Banks (CBK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- ResMed (RMD) Tops Q3 EPS by 20c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
